These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 468376)

  • 1. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii.
    Cisar JO; Kolenbrander PE; McIntire FC
    Infect Immun; 1979 Jun; 24(3):742-52. PubMed ID: 468376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis.
    Kolenbrander PE; Williams BL
    Infect Immun; 1981 Jul; 33(1):95-102. PubMed ID: 7263074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis.
    Kolenbrander PE
    Infect Immun; 1982 Sep; 37(3):1200-8. PubMed ID: 7129635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interbacterial adherence between Actinomyces viscosus and strains of Streptococcus pyogenes, Streptococcus agalactiae, and Pseudomonas aeruginosa.
    Komiyama K; Gibbons RJ
    Infect Immun; 1984 Apr; 44(1):86-90. PubMed ID: 6423545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Actinomyces and Streptococcus coaggregation groups among human oral isolates from the same site.
    Kolenbrander PE; Inouye Y; Holdeman LV
    Infect Immun; 1983 Aug; 41(2):501-6. PubMed ID: 6409807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of viridans streptococci exhibiting lactose-inhibitable coaggregation with oral actinomycetes.
    Kolenbrander PE; Williams BL
    Infect Immun; 1983 Aug; 41(2):449-52. PubMed ID: 6409806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of lactose-reversible coadhesion of Actinomyces naeslundii WVU 398A and Streptococcus oralis 34 on the surface of hexadecane droplets.
    Ellen RP; Veisman H; Buivids IA; Rosenberg M
    Oral Microbiol Immunol; 1994 Dec; 9(6):364-71. PubMed ID: 7870472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intergeneric bacterial coaggregations involving mutans streptococci and oral actinomyces.
    Crowley PJ; Fischlschweiger W; Coleman SE; Bleiweis AS
    Infect Immun; 1987 Nov; 55(11):2695-700. PubMed ID: 3117688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.
    McIntire FC; Vatter AE; Baros J; Arnold J
    Infect Immun; 1978 Sep; 21(3):978-88. PubMed ID: 30701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans.
    Jenkinson HF; Lala HC; Shepherd MG
    Infect Immun; 1990 May; 58(5):1429-36. PubMed ID: 2182544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coaggregation of oral Bacteroides species with other bacteria: central role in coaggregation bridges and competitions.
    Kolenbrander PE; Andersen RN; Holdeman LV
    Infect Immun; 1985 Jun; 48(3):741-6. PubMed ID: 3888842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Streptococcus gordonii (S. sanguis) PK488 adhesin-mediated coaggregation with Actinomyces naeslundii PK606.
    Kolenbrander PE; Andersen RN
    Infect Immun; 1990 Sep; 58(9):3064-72. PubMed ID: 2387635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of saliva on coaggregation of oral Actinomyces and Streptococcus species.
    Kolenbrander PE; Phucas CS
    Infect Immun; 1984 May; 44(2):228-33. PubMed ID: 6370861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextran-mediated interbacterial aggregation between dextran-synthesizing streptococci and Actinomyces viscosus.
    Bourgeau G; McBride BC
    Infect Immun; 1976 Apr; 13(4):1228-34. PubMed ID: 1279004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence of mutans streptococci to other oral bacteria.
    Lamont RJ; Rosan B
    Infect Immun; 1990 Jun; 58(6):1738-43. PubMed ID: 2341174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular coaggregation of oral Streptococcus milleri with actinomyces.
    Eifuku H; Yakushiji T; Mizuno J; Kudo N; Inoue M
    Infect Immun; 1990 Jan; 58(1):163-8. PubMed ID: 2294047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria.
    Kolenbrander PE; Andersen RN; Moore LV
    Infect Immun; 1989 Oct; 57(10):3194-203. PubMed ID: 2777378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34: beta-galactosides, related sugars, and anionic amphipathic compounds.
    McIntire FC; Crosby LK; Vatter AE
    Infect Immun; 1982 Apr; 36(1):371-8. PubMed ID: 7076303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coaggregation of oral lactobacilli with streptococci from the oral cavity.
    Willcox MD; Patrikakis M; Harty DW; Loo CY; Knox KW
    Oral Microbiol Immunol; 1993 Oct; 8(5):319-21. PubMed ID: 8265207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.